Executive function deficits in genetic frontotemporal dementia: results from the GENFI study
Author:
Russell Lucy L, Bouzigues Arabella, Convery Rhian SORCID, Foster Phoebe, Ferry-Bolder Eve, Cash David M.ORCID, van Swieten John C., Jiskoot Lize C., Seelaar HarroORCID, Moreno Fermin, Sanchez-Valle Raquel, Laforce RobertORCID, Graff CarolineORCID, Masellis Mario, Tartaglia Maria Carmela, Rowe James B.ORCID, Borroni Barbara, Finger Elizabeth, Synofzik MatthisORCID, Galimberti DanielaORCID, Vandenberghe RikORCID, de Mendonça Alexandre, Butler Chris, Gerhard AlexanderORCID, Ducharme Simon, Le Ber Isabelle, Santana IsabelORCID, Pasquier FlorenceORCID, Levin Johannes, Sorbi Sandro, Otto MarkusORCID, Rohrer Jonathan D.
Abstract
AbstractBackgroundExecutive dysfunction is a core feature of frontotemporal dementia (FTD). Whilst there has been extensive research into such impairments in sporadic FTD, there has been little research in the familial forms.Methods752 individuals were recruited in total: 214C9orf72, 205GRNand 86MAPTmutation carriers, stratified into asymptomatic, prodromal and fully symptomatic, and 247 mutation negative controls. Attention and executive function were measured using the Weschler Memory Scale-Revised (WMS-R) Digit Span Backwards (DSB), the Wechsler Adult Intelligence Scale-Revised Digit Symbol task, the Trail Making Test Parts A and B, the Delis-Kaplan Executive Function System Color Word Interference Test and verbal fluency tasks (letter and category). Linear regression models with bootstrapping were used to assess differences between groups. Correlation of task score with disease severity was also performed, as well an analysis of the neuroanatomical correlates of each task.ResultsFully symptomaticC9orf72, GRNandMAPTmutation carriers were significantly impaired on all tasks compared with controls (all p<0.001), except on the WMS-R DSB in theMAPTmutation carriers (p=0.147). Whilst asymptomatic and prodromalC9orf72individuals also demonstrated deficits compared with controls, neither theGRNorMAPTasymptomatic or prodromal mutation carriers showed significant differences. All tasks significantly correlated with disease severity in each of the genetic groups (all p<0.001).ConclusionsIndividuals withC9orf72mutations show difficulties with executive function from very early on in the disease and this continues to deteriorate with disease severity. In contrast, similar difficulties occur only in the later stages of the disease inGRNandMAPTmutation carriers. This differential performance across the genetic groups will be important in neuropsychological task selection in upcoming clinical trials.
Publisher
Cold Spring Harbor Laboratory
Reference77 articles.
1. A functional neuroimaging analysis of the Trail Making Test-B: implications for clinical application;Behavioural Neurology,2011 2. Conceptualization and Operationalization of Executive Function. Mind;Brain, and Education,2016 3. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 4. Benussi, A. , Alberici, A. , Samra, K. , Russell, L. L. , Greaves, C. V. , Bocchetta, M. , Ducharme, S. , Finger, E. , Fumagalli, G. , & Galimberti, D . (2021). Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimer’s & Dementia. 5. A Developmental Perspective on Executive Function
|
|